| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22f32896b0b8daace5aa333dde87f6e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
2016-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ae876ace65c907443978b7df16e7486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daebed6f79cf52b6c80961819eb2ada9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2249295fb405d18fd38d9738d2e753 |
| publicationDate |
2017-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017064289-A1 |
| titleOfInvention |
Colloidal particles for topical administration with therapeutic agent |
| abstract |
The invention provides a composition comprising a biologically active polypeptide or protein and a colloidal particle comprising approximately 0.5 to 20 mole percent of an amphipathic lipid derivatized with a biocompatible hydrophilic polymer for use in the treatment of a disease or condition wherein the colloidal particle is for topical administration prior to the biologically active polypeptide or protein which is for topical, intravenous or subcutaneous administration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023021111-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023021109-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023021115-A1 |
| priorityDate |
2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |